Vasomotor Rhinitis with Rhinorrhea: Next Step After Topical Ipratropium Has Not Achieved Reduced Rhinorrhea

Clinical Scenario

This protocol addresses vasomotor rhinitis where rhinorrhea (runny nose) is the predominant presenting symptom, with no nasal obstruction and no nasal congestion.

Previous Treatment — Goals Not Reached

An initial course of topical anticholinergic (ipratropium [Atrovent]) intranasally was the logical first step when rhinorrhea was the sole symptom. When the target of reduced rhinorrhea is not achieved, escalation to a next-line approach is warranted.

Next-Line Approach (Partial Overview)

The structured next step involves switching to a different class of topical intranasal agent. The full protocol specifies which therapy, how it replaces the prior treatment, and the clinical decision points that follow. That detail is available via the link below.

Treatment Goals

The target for this protocol is a meaningful decrease in sneezing and congestion.

Instant Access to Structured Evidence-Based Regimens

References

If the presenting symptom is solely rhinorrhea, a topical anticholinergic is the logical first step.

Substitute topical cromoglycate (cromolyn sodium [Intal]).

Decrease in sneezing and congestion scores.

View source ↗